Lifevantage (NASDAQ:LFVN) Stock Price Breaks Below 200-Day Moving Average Following Analyst Downgrade

Lifevantage Corporation (NASDAQ:LFVN – Get Free Report)’s stock price crossed below its 200-day moving average during trading on Monday after Zacks Research downgraded the stock from a hold rating to a strong sell rating. The stock has a 200-day moving average of $6.20 and traded as low as $5.94. Lifevantage shares last traded at $5.98, with a volume of 26,980 shares.

A number of other analysts also recently commented on LFVN. Weiss Ratings reiterated a “hold (c)” rating on shares of Lifevantage in a report on Friday, August 21st. Lake Street Capital raised their target price on shares of Lifevantage from $5.00 to $6.00 and gave the stock a “hold” rating in a research note on Friday, August 28th. Two equities research analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of “Reduce” and an average target price of $5.50.

View Our Latest Stock Report on LFVN

Insider Activity

In other Lifevantage news, insider Kristen Cunningham sold 8,901 shares of the business’s stock in a transaction that occurred on Monday, September 14th. The stock was sold at an average price of $6.18, for a total value of $55,008.18. Following the sale, the insider owned 120,162 shares of the company’s stock, valued at $742,601.16. The trade was a 6.90% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Company insiders own 13.58% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in LFVN. DGS Capital Management LLC purchased a new position in shares of Lifevantage in the 1st quarter valued at about $44,000. Hsbc Holdings PLC acquired a new stake in Lifevantage in the first quarter valued at approximately $51,000. Bank of New York Mellon Corp acquired a new stake in Lifevantage in the second quarter valued at approximately $78,000. Bank of America Corp DE lifted its stake in Lifevantage by 24.3% in the first quarter. Bank of America Corp DE now owns 23,445 shares of the company’s stock worth $101,000 after acquiring an additional 4,586 shares during the last quarter. Finally, Engineers Gate Manager LP lifted its stake in Lifevantage by 109.7% in the second quarter. Engineers Gate Manager LP now owns 27,009 shares of the company’s stock worth $169,000 after acquiring an additional 14,131 shares during the last quarter. Hedge funds and other institutional investors own 35.32% of the company’s stock.

Lifevantage Price Performance

The company has a market cap of $74.91 million, a PE ratio of 14.88 and a beta of 0.68. The business’s 50 day moving average is $6.27 and its 200-day moving average is $6.21.

Lifevantage (NASDAQ:LFVN – Get Free Report) last posted its quarterly earnings results on Thursday, August 27th. The company reported $0.11 earnings per share for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.01). The business had revenue of $42.38 million during the quarter, compared to analyst estimates of $44.00 million. Lifevantage had a net margin of 2.78% and a return on equity of 21.56%. As a group, sell-side analysts predict that Lifevantage Corporation will post 0.39 EPS for the current fiscal year.

Lifevantage Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 15th. Stockholders of record on Tuesday, September 1st were issued a $0.05 dividend. This represents a $0.20 annualized dividend and a dividend yield of 3.4%. The ex-dividend date of this dividend was Tuesday, September 1st. Lifevantage’s dividend payout ratio is presently 50.00%.

Lifevantage Company Profile

(Get Free Report)

LifeVantage Corporation is a health and wellness company that develops, markets and distributes nutritional supplements, skincare products and other wellness solutions. Its products are designed to support areas such as cellular health, energy, healthy aging and skin care.

The company’s product portfolio has included the Protandim line of dietary supplements, TrueScience skincare products and AXIO energy and wellness products. LifeVantage sells primarily through a direct-selling model, supported by independent distributors, as well as through digital commerce and other retail channels.

Founded in 2003 and headquartered in Lehi, Utah, LifeVantage serves customers in the United States and selected international markets, including Japan, Australia and Hong Kong.

Further Reading

Receive News & Ratings for Lifevantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lifevantage and related companies with MarketBeat.com's FREE daily email newsletter.